Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous

References

• AabergTM1988Management of anterior and posterior proliferative vitreoretinopathy: XLV Edward Jackson Memorial LectureAm J Ophthalmol106519323056014
   PubMed Web of Science ®Google Scholar
• AbramsGWAzenSPMcCuenBWIIfor the Silicone Study Group1997Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow up: Silicone Study Report 11Arch Ophthalmol115335449076205
   PubMedGoogle Scholar
• ArbisserLBCharlesSHowcroftM2006Management of vitreous loss and dropped nucleus during cataract surgeryOphthalmol Clin N Am19495506
   PubMedGoogle Scholar
• BakriSJShahAFaulkNS2005Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedemaEye19686815332099
   PubMed Web of Science ®Google Scholar
• BurkSEDa MataAPSnyderME2003Visualizing vitreous using Kenalog suspensionJ Cataract Refract Surg296455112686230
   PubMed Web of Science ®Google Scholar
• ChangCChiangSChenC2006Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsificationJ Cataract Refract Surg322054917137983
   PubMed Web of Science ®Google Scholar
• DoiNUemuraANakaoK2005Vitreomacular adhesion and the defect in the posterior vitreous cortex visualized by triamcinolone-assisted vitrectomyRetina255914
   Web of Science ®Google Scholar
• EnaidaHHataYUenoA2003Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseasesRetina237647014707824
   PubMed Web of Science ®Google Scholar
• FlomanNZorU1977Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin productionInvest Ophthalmol166973
   Google Scholar
• FraserEACheemaRARobertsMA2003Triamcinolone acetonide-assisted peeling of the retinal internal limiting membrane for macular surgeryRetina23883414707850
   PubMed Web of Science ®Google Scholar
• FukukitaMSasohMMatsubaraH2007Triamcinolone acetonide remaining on the fovea after successful macular hole closureRetina27122317218930
   PubMed Web of Science ®Google Scholar
• FurinoCFerrariTMBosciaF2003Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathyRetina23771614707825
   PubMed Web of Science ®Google Scholar
• GandorferAHaritoglouCGandorferA2003Retinal damage from indocyanine green in experimental macular surgeryInvest Ophthalmol Vis Sci443162312506091
   PubMed Web of Science ®Google Scholar
• GirardPMimounGKarpouzas1994Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgeryRetina14417247899716
   PubMed Web of Science ®Google Scholar
• HikichiFFurukawaYOhtsukaH2008Improvement of visual acuity one-year after vitreous surgery in eyes with residual triamcinolone acetonide at the macular holeAm J Ophthalmol1452677218054886
   PubMed Web of Science ®Google Scholar
• HirataFTamuraHOguraY2005Visualization of residual perfluorocarbon liquid using intravitreal triamcinolone acetonideOphthalmic Surg Lasers Imaging361697215792323
   PubMedGoogle Scholar
• HorioNHoriguchiMYamamotoN2005Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgeryArch Ophthalmol12396915642818
   PubMedGoogle Scholar
• JonasJBHaylerJKPanda-JonesS2000Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathyBr J Ophthalmol841064710966969
   PubMed Web of Science ®Google Scholar
• KampougerisGChemmaRMcPhersonR2007Safety of triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgeryEye21591416456587
   PubMed Web of Science ®Google Scholar
• KaracorluMOzdemirHKaracoriuSA2005Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery?Graefe’s Arch Clin Exp Ophthalmol2437547
   Web of Science ®Google Scholar
• KimuraHKurodaSNagataM2004Triamcinolone acetonide-assited peeling of the internal limiting membraneAm J Ophthalmol137172314700661
   PubMed Web of Science ®Google Scholar
• KumagaiKFurukawaMOginoN2007Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peelingRetina2712495418046233
   PubMed Web of Science ®Google Scholar
• LewisGDCampbellWBJohnsonAR1986Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cellEndocrinology1996293087737
   PubMed Web of Science ®Google Scholar
• MatsumoHYamanakaIHisatomiT2007Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removalRetina27174917290199
   PubMed Web of Science ®Google Scholar
• PeymanGACheemaRConwayM2000Triamcinolone acetonide as an aid to visualization of vitreous and the posterior hyaloid during pars plana vitrectomyRetina20554511039438
   PubMed Web of Science ®Google Scholar
• RodriguesEBMeyerCHKrollP2005Chromovitrectomy: a new field in vitreoretinal surgeryGraefe’s Arch Clin Exp Ophthalmol2432913
   PubMed Web of Science ®Google Scholar
• SakamotoTMiyazakiMHisatomiT2002Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdownGraefe’s Arch Clin Exp Ophthalmol2404239
   PubMed Web of Science ®Google Scholar
• ShahGKRosenblattBJBlinderKJ2005Triamcinolone-assisted internal limiting membrane peelingRetina25972516340525
   PubMed Web of Science ®Google Scholar
• ShahGKRosenblattBJSmithM2004Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmationAm J Ophthalmol138656715488800
   PubMed Web of Science ®Google Scholar
• SonodaKEnaidaHUenoA2003Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series studyBr J Ophthalmol8710101412881346
   PubMed Web of Science ®Google Scholar
• SonodaKSakamotoTEnaidaH2004Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonideAm J Ophthalmol11122630
   Google Scholar
• TakeuchiMKatagiriYUsuiM2003Residual triamcinolone acetonide in the macular hole after vitrectomyAm J Ophthalmol1361174614644240
   PubMed Web of Science ®Google Scholar
• TognettoDZenoniSSanguinettiG2005Staining of the internal limiting membrane with intravitreal triamcinolone acetonideRetina25462715933593
   PubMed Web of Science ®Google Scholar
• UenoAEnaidaAHataY2007Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: A case studyEu J Ophthalmol73928
   Web of Science ®Google Scholar
• VeckeneerMvan OverdamKMonzerJ2001Ocular toxity study of trypan blue injected into the vitreous cavity of rabbit eyesGraefes Arch Clin Exp Ophthalmol23969870411688671
   PubMed Web of Science ®Google Scholar
• YamakiriKSakamotoTNodaY2007Reduced incidence of intra-operative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomyOphthalmology114189296
   Web of Science ®Google Scholar
• YamakiriKSakamotoTNodaY2008One-year results of a multi-center controlled clinical trial of triamcinolone in pars plana vitrectomyGraefes Arch Clin Exp Ophthalmol2469596618431588
   PubMed Web of Science ®Google Scholar
• YamakiriKUchinoEKimuraK2006Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgeryJ Cataract Refract Surg322054917137983
   PubMed Web of Science ®Google Scholar
• YamashitaTDoiNSakamotoT2004Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomyGraefe’s Arch Clin Exp Ophthalmol24267981
   PubMed Web of Science ®Google Scholar